Evidence map›Paper›PMID 16568205›Full record

Trial reportEuropean journal of nuclear medicine and molecular imaging2006

[18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers.

Wolfgang Wadsak, Markus Mitterhauser, Gundula Rendl, Matthias Schuetz, Leonhard Key Mien, Dagmar E Ettlinger, Robert Dudczak, Kurt Kletter, Georgios Karanikas

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nuclear medicine and molecular imaging, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Development of [Journal of medicinal chemistry · 2021
    Article
  3. Para-chloro-2-[International journal of medical sciences · 2021
    Article
  4. Review
  5. Molecular imaging of adrenal neoplasms.Journal of surgical oncology · 2012
    Review
  6. Review
  7. Review
  8. Imaging and cancer: a review.Molecular oncology · 2008
    Review
  9. Something old, something new, PET in adrenal imaging.European journal of nuclear medicine and molecular imaging · 2008
    Article
  10. [18F]FETO: metabolic considerations.European journal of nuclear medicine and molecular imaging · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wolfgang WadsakDepartment of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. wolfgang.wadsak@meduniwien.ac.at
Markus Mitterhauser
Gundula Rendl
Matthias Schuetz
Leonhard Key Mien
Dagmar E Ettlinger
Robert Dudczak
Kurt Kletter
Georgios Karanikas

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeFunctional imaging of the adrenal cortex by means of PET may play an important clinical role. Recently, we presented the synthesis and first evaluation of a novel 11beta-hydroxylase inhibitor, [(18)F]FETO, in rats displaying high tracer accumulation in the adrenals. In this study, we aimed to investigate for the first time the potency of [(18)F]FETO as a PET tracer for the adrenal cortex in humans.

methodsAn average preparation yielded 1-2 GBq of [(18)F]FETO ready to use. Ten healthy volunteers aged 24-57 years (five male and five female) were included in the study. After i.v. administration of 365 MBq [(18)F]FETO (246-391 MBq), dynamic images were acquired in 2D standard mode in 14 frames over 45 min. Afterwards, whole-body scanning was performed. In addition to visual interpretation, semi-quantitative analysis using standardised uptake values (SUVs) was conducted.

results[(18)F]FETO distribution was similar in all scanned volunteers. Visually, pronounced accumulation of [(18)F]FETO was found in the adrenals, whereas moderate uptake was observed-at least in some of the subjects-for liver, renal calices, gallbladder, stomach walls and pancreas. Kidney and bowels showed only faint uptake. Median SUVs for the right and left adrenal glands were 15.6 (10.0-28.6) and 15.7 (10.3-35.9), respectively. The reference tissue (liver) displayed a median SUV of 2.5 (2.2-4.6).

conclusion[(18)F]FETO is a valuable tracer for adrenocortical PET imaging, combining the longer half-life of( 18)F with a high 11beta-hydroxylase selectivity. In accordance with our findings in rats, FETO PET revealed very high accumulation in the adrenal glands in healthy volunteers.

Indexed as

Adrenal CortexAdultFemaleHumansImidazolesMaleMetabolic Clearance RateMiddle AgedOrgan SpecificityPilot ProjectsPositron-Emission TomographyRadiopharmaceuticalsReference ValuesTissue DistributionWhole Body Imaging1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid 2-fluoroethylesterImidazolesRadiopharmaceuticals

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.